CA2085975C - Dentinal desensitizing compositions - Google Patents

Dentinal desensitizing compositions

Info

Publication number
CA2085975C
CA2085975C CA002085975A CA2085975A CA2085975C CA 2085975 C CA2085975 C CA 2085975C CA 002085975 A CA002085975 A CA 002085975A CA 2085975 A CA2085975 A CA 2085975A CA 2085975 C CA2085975 C CA 2085975C
Authority
CA
Canada
Prior art keywords
oral composition
agent
desensitizing
weight
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002085975A
Other languages
French (fr)
Other versions
CA2085975A1 (en
Inventor
Richard M. Lim
James K. Herms
William S. Fertel
Joseph Synodis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Block Drug Co Inc
Original Assignee
Block Drug Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Block Drug Co Inc filed Critical Block Drug Co Inc
Publication of CA2085975A1 publication Critical patent/CA2085975A1/en
Application granted granted Critical
Publication of CA2085975C publication Critical patent/CA2085975C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Abstract

A composition containing a water soluble or water swellable polyelectrolyte or salts thereof in a dentifrice base or other oral compositions which can be used for relieving pain and discomfort caused by hypersensitive teeth. The salts can be single or mixed partial salts of the polyelectrolyte.

Description

D~:N'1'1~AL DESENSITIZING COMPOSITIONS

Hypersensitive teeth can cause pain and discomfort when subjected to changes in temperature, pressure, or chemical action. EX~G~U~ e of the dentln frequently leads to hypersensitivity. Dentin exposure may occur due to recession of the gums, periodontal disease and improper dental care. The usual method of treating hypersensitive teeth employs a desensitizing dentifrice or solution. Some of the active ingredients used in desensitizing dentifrices include strontium chloride, strontium acetate, potassium nitrate, and potassium chloride. Other treatments are applied professionally as a solution. These include solutions of ferric oxalate or potassium oxalate.
One approach to desensitization is to occlude exposed dentinal tubules. Dentinal tubules lead from the pulp to the surface of the dentin. When the surface of the tooth is eroded, the dentinal tubules become exposed to the external environment. The exposed dentinal tubules provide a pathway for transmlssion Of flui~ flow to the pulpal nerves and this is induced by changes in temperature, pressure and ionic gradients. By blocking the tubules, the external stimuli have a diminished effect, and less pain will be felt.
Some active ingredients, such as ferric oxalate, are known to form mineral deposits on the #194 '~ 208597~

surfaces of exposed dentinal tubules, effectively blocking the openings. In some cases, the abrasive action from brushing may cause a smear layer to form over the surface of the tooth and thus plug up the open tubules. The accumulation of particulate matter from the interstitial fluid passing through the dentinal tubules or remineralization within the tubules can cause a natural occlusion of the tubules.
Nerve inactivation is another mechanism whereby desensitization can occur. This relies on the action of an active ingredient such as potassium nitrate on the nerves. By altering the ionic balance in the nerve, the threshold of nerve stimulation is increased. Thus a higher level of stimulation is needed to evoke a painful response.
The materials which have been used as active ingredients in the treatment of hypersensitive teeth are generally inorganic salts or hydrophobic compounds.
Although hydrophilic polymers have been used in oral compositions as excipients or the like, they have not been suggested as being useful active ingredients for desensitization purposes. Most of the hydrophilic polymers have been used to control the viscosity of the oral formulation or to give it thixotropic properties.
An example of such a polymer is polyacrylic acid which is used as a thickener in dentifrice formulations. It has also been used in gels, mouthwashes and buccal adhesive patches. However, polyacrylic acid has also been used for other purposes. For example, Leonard et al. (U.S. Patent 5,011,830) state an oral ~Y194 2~85975 composition containing an alkali pyrophosphate salt, a fluoride salt and a polyacrylic acid or a copolymer of acrylic acid and another monomer can provide P~hAn~
anti-calculus benefits. Gaffar (U.S. Patent 3,956,480) uses an anionic polymer such as polyacrylic acid with chlorhexidine as an anti-calculus agent. Benedict and Sunberg (U.S. Patent 4,661,341) describe the use of polyacrylic acid or copolymers of polyacrylic acid as anti-calculus agents.
Another polymer which is used in oral compositions is the copolymer of methyl vinyl ether and maleic anhydride (MVE/MA) or the hydrolyzed acid copolymer. The MVE/MA copolymer and its salts have been used to enhance anti-calculus, anti-plaque, and anti-caries activity, and to control mouth odor. It has also been used to stabilize active agents in dentifrice formulations.
Suhonen (U.S. Pat. 4,960,586; 4,961,924) uses the MVEIMA copolymer to stabilize stannous fluoride dentifrice compositions.
Gaffar et al. (U.S. Pat. 4,138,477) use a zinc compound with the MVE/MA copolymer in a composition to control mouth odor and also to prevent calculus, caries, plaque, and periodontal disease.
Wietfeldt (U.S. Pat. 4,965,067) uses the MVE/MA
copolymer, a soluble fluoride ion source, and a strontium ion source in a dentifrice composition. The polymer is said to stabilize the combination of strontium and fluoride in the composition which will form a precipitate without stabilization.

#194 7 ~

Friedman (EP 0381445) claims an oral composition with an anti-hypersensitivity agent such as strontium chloride in a hyd~o~hobic polymer which can be applied to the teeth. The polymer matrix has an affinity for the teeth and acts as a matrix for the sustained release of the active ingredient. An example of a carrier used is ethyl cellulose with polyethylene glycol as a plasticizer.
Mason (U.S. Pat. 4,992,258J discloses the use of montmorillonite clay and a MVE/MA copolymer in a dentifrice formulation for the treatment of hypersensitive teeth. It is asserted in this patent that the MVE/MA copolymer increases the effectiveness of the montmorillonite clay.
lS In none of the examples above or elsewhere, as far as we are aware, are these polymers claimed to provide a desensitizing effect. Even in the Mason patent where a MVE/MA copolymer was used to increase the effectiveness of a ~eC~citizing agent there is no attribution of such properties to the polymer.
Zinner et al., A New Desensitizing Dentrifice:Preliminary Report, JADA, Vol. 95 pp. 982-985, November 1977 reports that a Pluronic F127 based dentrifice, with or without sodium citrate, had some desensitizing efficacy. Pluronic F127 is a non-ionic water soluble copolymer of ethylene oxide and propylene oxide.
It has now been determined that water soluble or water swellable polyelectrolytes, i.e. polymers with functional groups that are capable of bearing one or more *Trademark 2~S5975 charged groups in an aqueous solution have desensitizing properties.
It is accordingly the object of this invention to provide new dentinal desensitizing agents. This and other objects of the invention will become apparent to those skilled in this art from the following detailed description.

This invention relates to an oral composition and method which is useful for relieving pain and discomfort caused by hypersensitive teeth. More particularly, the invention relates to the use of a water soluble or water swellable polyelectrolyte or the partial salts thereof as a dental desensitization agent. The cations used to make the salt can include ammoniùm, alkylammonium, calcium, sodium, potassium, strontium, magnesium, zinc, aluminum, tin, iron, barium, lanthanum, titanium, bismuth and copper. The salts may contain single cations or mixed cations.
The polymer and its salts may be formulated into a dentifrice, gel, buccal adhesive patch, mouthwash, lozenge, or gum. Use of these oral compositions on a regular basis can provide relief from the pain and discomfort of hypersensitive teeth. The oral composition described above may also provide for a sustained release mode of action for the delivery of strontium or potassium ions from the water soluble or water swellable polyelectrolytes. The polyelectrolytes may also be used in conjunction with additional desensitizing agents such #194 2~)8597~3 as strontium chloride or potassium nitrate in an oral composltion .

In accordance with the present invention, a water soluble or water swellable polyelectrolyte is used as a dentinal desensitizing agent. The agent can be - incorporated into a dentrifice, gel, mouthwash, lozenge, buccal adhesive patch, gum or the like. The water soluble or swellable polymers are generally polyelectrolytes, that is, polymers which bear one or more functional groups capable of bearing a charge in an aqueous medium. These polyelectrolytes can be anionic, cationic or amphoteric.
one example of an anionic functional group is the carboxylate group. This group is found in such polymers as polyacrylic acid, copolymers of acrylic acid and maleic acid, copolymers of methacrylic acid and acrylic acid, copolymers of alkyl vinyl ethers and maleic acid or anhydride, and the like. In the alkyl vinyl ether/maleic acid or anhydride copolymers, the alkyl group generally contains 1 to about 10 carbon atoms and is most preferably a methyl group. The copolymer can be produced using procedures well known in the art or commercially available forms can be employed. For instance, the methyl vinyl ether/maleic anhydride copolymer can be obtained from International Specialty Products under the tradename Gantrez~ - AN or as the hydrolyzed acid under the tradename Gantrez~ - S.
Polyacrylic acid can be obtained from B.F. Goodrich under #194 2u8s97s the tradename Carbopol0 or Noveon~ as a cross-linked polyacrylic acid. Polyacrylic acid can also be obt~in~A
from Rohm and Haas under the tradename Acusol~. These and other usable anionic polyelectrolytes are available from various other manufacturers. Another anionic functional group is the sulfonate group which is found for instance in sodium polystyrene sulfonate polymers.
The polyelectrolytes can contain cationic functional groups such as quaternized amines, imines, amides and alkyl ammonium groups. Examples include copolymers of vinyl pyrrolidone and dialkyl aminoalkyl methacrylates, chitosan, cationic celluloses and the like. A copolymer of vinyl pyrrolidone and dialkyl aminoalkyl methacrylate is available from International Specialty Products under the tradename Gafquat~.
Chitosan is available under various tradenames from several companies.
Amphoteric polymers can also be used as a dentinal desensitizing agent. Examples include the aminoalkyl methacrylate and acrylates, copolymers of aminoalkyl acrylamides and acrylates, gelatin and the like.
The foregoing polymers are illustrative. The main criteria are that the polymer is water soluble or water swellable and contains functional groups capable of bearing a charge.
The commercially available polymers are produced over a range of molecular weights. ThUs, for instance, Gantrez~ - AN is available as a high molecular weight grade (Gantrez~ - AN-179 MW=80,000) down to a low #194 208~975 ,~

molecular weight grade (Gantrez~ AN-119 MW=30,000).
Similarly, Carbopol~ and Noveon~ are available in different grades with different rheological properties.
The different grades range in molecular weight from 5 450,000 (907 type) to 4,000,000 (940 type). It is preferable to employ the highest molecular weight grade consistent with the viscosity of the formulation being prepared and concentration of the agent. The formulations will contain a desensitizing amount which is generally of from about 0.1% to 30% by weight of the polymer or its partial salts, with about 1-15% being preferred and about 2-12% most preferred. For any given concentration, viscosity generally increases with molecular weight and for any given molecular weight, viscosity generally increases with concentration.
The properties of some of these polymers may be modified to obtain the most advantageous properties by neutralization or partial neutralization. The cation may be present in the salts at about 20% to 100% equivalent mole ratio of the polymer. The preferred range is from about 40% to 90% equivalent of the polymer. The cations that can be used include ammonium, alkylammonium, calcium, sodium, potassium, strontium, zinc, aluminum, magnesium, tin, iron, barium, lanthanum, titanium, bismuth and copper. The cations can be used singly or as a mixture of different cations. These salts as such are well known in the art.
The salts of the copolymer can be made by making a solution of the polymer in water and then adding a metal salt such as the hydroxide, carbonate, ~Y194 bicarbonate, oxide, acetate, citrate, lactate or formate.
The metal salt is preferably alkaline. The solution is stirred, with heating if necessary, until the polymer has dissolved. It will usually have a pH between about 3.5 and 9, depending on the amount of metal salt used. The salt solution can be directly incorporated into an aqueous oral composition. Alternatively, the solution can be evaporated to dryness to give a solid salt which can be milled to a fine powder, if desired, and incorporated into an oral composition.
The polymer or its salts can be formulated into a dentifrice, mouthwash, lozenge, buccal adhesive patch or gum using ingredients and procedures which are well known and commonly used in preparing these oral compositions. By way of example, without limitation, it is possible to incorporate a fluoride source into the oral composition. Of course, the ingredients used to make the above oral compositions should be compatible with the polymer and its salts. It is also possible to formulate the oral compositions in conjunction with additional desensitizing agents. Additional desensitizing agents include, without limitation, sodium fluoride, sodium silicofluoride, zinc chloride, formaldehyde, glycerin and silver nitrate. Additional desensitizing agents may also include potassium-containing compounds, such as potassium nitrate, as described in U.S. Patent 3,863,006 and strontium-containing compounds, such as strontium chloride, as described in U.S. Patent 3,122,483.

~194 The polyelectrolytes have an affinity for the tooth surface and can maintain their presence over a period of time. During that period, the MVE/MA copolymer salts that contain potassium or strontium or other actives can slowly release the ions into the oral environment. This allows for a longer term availability of the actives for desensitization.
In order to further illustrate the present invention, various non-limiting examples are set forth below. In these examples, as throughout this specification and claims, all temperatures are in degrees centigrade and all parts and percentages are by weight unless otherwise indicated.
Exam~le 1 A dispersion of 156g Gantrez~ AN-169 (MW=67,000) in 1.8 liters of water was stirred vigorously with heating and a slurry of 133g strontium hydroxide, octahydrate in 320g of water was slowly added to the mixture. The mixture was heated to 90~C whereupon it started to become clear. Then the solution was allowed to cool to 70~C and stirred at that temperature for an additional 2 hours. A 9% solution of a strontium (50%
equivalent) MVE/MA salt was thus obtained. This solution was used as is or was evaporated to dryness and then milled to a fine powder.
Example 2 A 12% solution of a potassium (40% equivalent) salt of the MVE/MA copolymer was made using 156g of Gantrez~ AN-169 and 45g of potassium hydroxide in 1.5 liters of water following the procedure in Example 1.

#194 2 1)~59~5 This solution was used to make a dentifrice using the following ingredients:
INGREDIENT % WEIGHT
12% Solution of MVE/MA 60.3%
(40% equivalent potassium salt) Sorbitol 11.4%
Glycerin 12.0%
Carboxymethyl cellulose2.4%
Diatomaceous earth 10.1%
Sodium lauryl sulfate (SLS) 0.6%
TiO2 1. 0%
Fumed silica 1.6%
Flavor and preservative0.6%
The dentifrice was made by mixing the 12% solution of the partial potassium (40% equivalent) MVE/MA salt, sorbitol, glycerin, silica, SLS, and Tio2 together. After mixing, the carboxymethyl cellulose was added and blended into a homogeneous mixture.
Example 3 A dentifrice was prepared from:
INGREDIENT % WEIGHT
6% Solution of MVE/MA60.3%
(80% equivalent sodium salt) Tio~ 1. 0%
Sorbitol 12%
Fumed silica 1.6%
caC03 10. 1%
Glycerin 12%
Carboxymethyl cellulose2.4%
SLS 0.6%

#194 1_ 208597~

The dentifrice is made in a manner similar to that described in Example 2.

ExamDle 4 A gel containing a sodium (80% equivalent) salt 5 of polyacrylic acid was prepared from the following ingredients:
INGREDIENT % WEIGHT
Polyacrylic Acid 2.9%
Sodium hydroxide 1.3%
Glycerine 21.0%
Potassium Nitrate 5.0%
Water 69.8%
Exam~le 5 A dentrifice containing a 5% polyacrylic acid 15 (80% equivalent sodium salt) was prepared from the following ingredients:
INGREDIENT % WEIGHT
Polyacrylic Acid 4.0%
Sodium hydroxide 1.8%
Glycerin 20.0%
Potassium Nitrate 5.0%
Silica 3.9%
Pluronic F-87* 2.5%
Flavors & Preservatives0.7%
Water 62.1%
* Copolymer of ethylene oxide and propylene oxide Exam~le 6 A gel was prepared from the following ingredients:

#194 ~ 2~85~75 INGREDIENT % WEIGHT
Gelatin Type A 14.3%
Calcium chloride, dihydrate5.7%
Urea 5.7%
Water 74-3%
The pH was adjusted to 6.7 using sodium hydroxide.
Exam~le 7 A desensitizing solution was made from the following ingredients:
INGREDIENT % Weight Vinyl pyrrolidone/dimethyl-amino ethyl methacrylate copolymer 5%
Sodium chloride 0.6%
Water 94.4%
The pH was adjusted to 7.7.
Exam~le 8 A desensitizing gel was made from the following ingredients:
INGREDIENT % Weiqht Chitosan lactate 6%
Water 94%
The pH was adjusted to pH 5.
Exam~le 9 A desensitizing solution was made from the following ingredients:
INGREDIENT % Weight Poly (dimethyl diallyl-ammonium chloride) 6%

Sodium Chloride 0.6%
Water 93-4%

#194 208597~

Tests Of Oral Compositions Of Exam~les 1-9 The prepared solutions and oral compositions were tested using the method described by Pashley (J.
Periodontology, Vol. 55, No. 9, p. 522, Sept. 1984).
This test measures the flow of fluid through a sliced dentin disc. A treatment that will reduce the flow through the discs can also result in reduced dentinal hypersensitivity for people using the treatment.
A caries free tooth is sliced to obtain a 0.4 to 0.6 mm thick dentin disc. The disc is mounted on a split chamber device (J. Dent. Research 57:187, 1978).
The initial flow of fluid through the disc is measured, and then the disc is treated by brushing with one of the desensitizing treatments. After brushing, the flow rate is again measured and the reduction in flow is calculated from these measurements. The following compositions were used and the reduction in flow is reported. The results for the dentifrices are based on 1 to 1 dilution with artificial or human saliva.
Treatment % Chanqe in Flow Example 1 -43%
Example 2 -47%
Example 3 -39%
Example 4 -48%
Example 5 -63%
Example 6 -57%
Example 7 -80%
Example 8 -69%
Example 9 -59%

#194 - 208~975 Exam~le 10 A mouthwash was made by mixing the following ingredients:
INGREDIENT % WEIGHT
10.3% solution of NVE/MA
(90% equivalent sodium salt) 70%
Alcohol 190 Proof (Grain Alcohol) 10%
Pluronic F-127 2%
Flavor 0.3%
Menthol 0.02%
Water q.s. to 100%

Example 11 The following composition was used to make a chewing gum:
INGREDIENT % WEIGHT
Chewing gum NOVA Base "A" 24.64%
Glycerin 1%
Calcium saccharin 0.06%
Sorbitol powder 53.5%
Lycasin 13%
Lecithin 0.8%
Flavor 1%
Chitosan lactate 6%
25 The chewing gum base was softened at 65~C using a sigma blade mixer, cooled to 60~C and 3/5 of the sorbitol powder and calcium saccharin added, followed by the glycerin. Then 1/5 of the sorbitol powder, 1/2 of the lycasin and the chitosan were added. After cooling to #194 208597~

50~C, the rest of the sorbitol powder, lycasin, and flavor were added. The mixture was rolled into patties and cut into strips.

Exam~le 12 S The following composition was used to make a lozenge:
INGREDIENT % WEIGHT
Sorbitol 86.5%
Xylitol 6 %
Citric Acid 0.4%
Flavor 0.1 Gelatin 7 %

The sorbitol and xylitol were heated at 165~C until the base started to thicken. The combination was cooled to 140~C and the citric acid added. After cooling to 100~C, the gelatin was added and after cooling to 85~C, the flavor was added. Cooling was continued and a seed crystal of sorbitol was added to start crystallization.
The mixture was poured into molds to form lozenges.
Various changes and modifications can be made in the process and products of this invention without departing from the scope thereof. The various embodiments described herein were for the purpose of further illustrating the invention but were not intended to limit it.

~194

Claims (10)

1. In an oral composition containing a desensitizing agent, the improvement which comprises the desensitizing agent being at least one water soluble or water swellable polyelectrolyte.
2. The oral composition of claim 1 wherein the polyelectrolyte contains a functional group selected from the group consisting of carboxylate, carboxy, amino alkylammonium and mixtures thereof.
3. The oral composition of claim 1 in which the agent contains a carboxyl functional group or the sale of the carboxyl functional group having a degree of neutralization from about 20 to 100% in which the cation is selected from the group consisting of ammonium, alkylammonium, calcium, sodium, potassium, strontium, zinc, aluminum, manganese, tin, iron, barium, lanthanum, titanium, bismuth and copper.
4. The oral composition of claim 1 in which the agent is a methyl vinyl ether/maleic acid or anhydride copolymer or salt thereof.
5. The oral composition of claim 1 in which the agent is polyacrylic acid or salt thereof or gelatin.
6. The oral composition of claim 1 in the form of a dentifrice mouthwash, gel, chewing gum, lozenge or buccal adhesive patch.
7. The oral composition of claim 1 in which the amount of desensitizing agent is about 0.1 to 30% by weight of the composition.
8. The oral composition of claim 10 in which the amount is about 1 to 15% by weight.
9. The oral composition of claim 11 in which the amount is about 2 to 12% by weight.
10. A tooth desensitizing composition comprising at least one water soluble or water swellable polyelectrolyte, together with an acceptable carrier therefore.
CA002085975A 1991-12-20 1992-12-21 Dentinal desensitizing compositions Expired - Fee Related CA2085975C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/811,811 US5270031A (en) 1991-12-20 1991-12-20 Dentinal desensitizing compositions
US811,811 1991-12-20

Publications (2)

Publication Number Publication Date
CA2085975A1 CA2085975A1 (en) 1993-06-21
CA2085975C true CA2085975C (en) 1999-03-30

Family

ID=25207656

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002085975A Expired - Fee Related CA2085975C (en) 1991-12-20 1992-12-21 Dentinal desensitizing compositions

Country Status (15)

Country Link
US (3) US5270031A (en)
EP (1) EP0549281B1 (en)
JP (1) JP2821967B2 (en)
KR (1) KR0169140B1 (en)
AT (1) ATE178786T1 (en)
AU (1) AU655695B2 (en)
BR (1) BR9204695A (en)
CA (1) CA2085975C (en)
DE (1) DE69228922T2 (en)
DK (1) DK0549281T3 (en)
ES (1) ES2133309T3 (en)
GR (1) GR3030422T3 (en)
MX (1) MX9207317A (en)
NZ (1) NZ245459A (en)
PH (1) PH30209A (en)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374417A (en) * 1991-10-17 1994-12-20 Colgate Palmolive Company Desensitizing dentifrice
US5240697A (en) * 1991-10-17 1993-08-31 Colgate-Palmolive Company Desensitizing anti-tartar dentifrice
US5270031A (en) * 1991-12-20 1993-12-14 Block Drug Company Inc. Dentinal desensitizing compositions
US5340370A (en) * 1993-11-03 1994-08-23 Intel Corporation Slurries for chemical mechanical polishing
ES2164753T3 (en) * 1993-11-15 2002-03-01 Block Drug Co ORGANOLEPTICALLY STABLE TABLETS FOR CLEANING DENTURES.
US5505933A (en) * 1994-06-27 1996-04-09 Colgate Palmolive Company Desensitizing anti-tartar dentifrice
US5874066A (en) * 1994-08-01 1999-02-23 University Of Maryland, Baltimore Method and kit for treating tooth hypersensitivity
JPH10505831A (en) * 1994-09-15 1998-06-09 ザ、プロクター、エンド、ギャンブル、カンパニー Oral composition
US5547657A (en) * 1994-10-11 1996-08-20 Eastman Chemical Company Low-irritation anesthetic and antiseptic mouth rinse
US5589159A (en) * 1995-04-11 1996-12-31 Block Drug Company Inc. Dispersible particulate system for desensitizing teeth
GB9515597D0 (en) * 1995-07-29 1995-09-27 Procter & Gamble Oral compositions
US5693315A (en) * 1996-06-10 1997-12-02 Abco Trust Mammal tooth treating composition
US5885551A (en) * 1997-08-01 1999-03-23 Smetana; Alfred J. Treatment for dentinal hypersensitivity
US6096292A (en) * 1998-07-28 2000-08-01 Block Drug Company, Inc. Polymeric desensitizing compositions
US6458339B1 (en) 2000-02-11 2002-10-01 Charles F. Cox Acid resistant film forming dental composition and method of use
US6241972B1 (en) 1999-02-19 2001-06-05 Block Drug Company, Inc. Oral care formulation for the treatment of sensitivity teeth
US6592853B2 (en) * 1999-03-10 2003-07-15 Block Drug Company, Inc. Dentin desensitizer containing stannous fluoride
NZ524610A (en) 1999-03-12 2004-09-24 Pfizer Prod Inc Composition containing a soluble potassium salt, a sodium alkylsulphonate, a polar surfactant and a carrier, use as a toothpaste, oral rinse, skin detergent, shampoo, hard surface cleaner and a fabric detergent
PL356027A1 (en) * 1999-12-03 2004-06-14 Gaba International Ag Oral hygiene agents containing amine hydrofluoride
US20070059257A1 (en) * 2000-08-18 2007-03-15 Block Drug Company, Inc. Dentinal composition for hypersensitive teeth
EP1331919A4 (en) * 2000-08-21 2005-11-16 Block Drug Co Dental composition for hypersensitive teeth
EP1731132B1 (en) 2000-10-13 2008-12-10 Block Drug Company, Inc. Dental compositions for hypersensitive teeth
EP1333796A4 (en) 2000-10-13 2004-12-01 Block Drug Co Anhydrous dentifrice formulations for the delivery of incompatible ingredients
US6416745B1 (en) 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth
KR20030006788A (en) * 2001-07-16 2003-01-23 이승진 Sustained release polymeric preparation for treatment of periodontal disease
DE10312173A1 (en) * 2003-03-19 2004-09-30 Ingo Hornung Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac
JP4962850B2 (en) * 2004-04-26 2012-06-27 独立行政法人国立循環器病研究センター Nerve transmission switching material
BRPI0512478A (en) * 2004-07-02 2008-03-11 Discus Dental Impressions Inc prescription fluoride treatment composition
CA2587044C (en) * 2004-11-09 2014-04-15 Discus Dental Impressions, Inc. Two component dental whitening compositions
JP5179705B2 (en) * 2005-03-31 2013-04-10 三星食品株式会社 Novel candy composition and novel candy using the same
US8263143B2 (en) 2005-08-22 2012-09-11 Kraft Foods Global Brands Llc Degradable chewing gum
US8282971B2 (en) 2005-08-22 2012-10-09 Kraft Foods Global Brands Llc Degradable chewing gum
US8268371B2 (en) 2005-08-22 2012-09-18 Kraft Foods Global Brands Llc Degradable chewing gum
ES2432217T3 (en) * 2005-11-18 2013-12-02 Intercontinental Great Brands Llc Degradable chewing gum
US20070183989A1 (en) * 2005-12-21 2007-08-09 Michael Prencipe Oral Compositions Comprising Zinc Citrate and/or Tocopherol Agents
US20070140990A1 (en) 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
US20070140992A1 (en) * 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
JP5038331B2 (en) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー Anti-aging treatment using copper and zinc composition
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
EP1993568A2 (en) * 2006-02-23 2008-11-26 The Research Foundation Of State University Of New York Method of treating periodontitis and of reducing dentinal sensitivity
US20070218018A1 (en) * 2006-03-15 2007-09-20 Discus Dental Impressions, Inc. Sensitivity relief gel
US20070243142A1 (en) * 2006-04-12 2007-10-18 Discko John J Dental liquid desensitizing preparation with resistant flow
US8900558B2 (en) * 2006-06-30 2014-12-02 Colgate-Palmolive Company High fluoride ion oral care composition and method for maintaining anticaries activity
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
DE102006046952A1 (en) 2006-10-04 2008-04-10 Ley, Fritz, Dr. Dental, in particular remineralizing and pain-sensitive teeth effective composition and dental particles, in particular for the composition
US20080268001A1 (en) * 2007-04-30 2008-10-30 Lynette Zaidel Oral care composition to reduce or eliminate dental sensitivity
WO2008145475A1 (en) * 2007-05-31 2008-12-04 Unilever Plc Oral care composition
WO2009067237A1 (en) * 2007-11-20 2009-05-28 Sasi Kumar Sunkara Formulation and method for treatment of teeth
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
GB0801836D0 (en) * 2008-01-31 2008-03-05 Glaxo Group Ltd Novel composition
JP6034549B2 (en) 2008-02-08 2016-11-30 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company Oral care products and methods of use and manufacture thereof
AU2012204031B2 (en) * 2008-02-08 2013-09-05 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110008271A1 (en) * 2009-07-13 2011-01-13 Jr Chem, Llc Rosacea treatments using polymetal complexes
GB0912768D0 (en) 2009-07-22 2009-08-26 Glaxo Group Ltd Novel composition
US9968803B2 (en) 2009-10-29 2018-05-15 Colgate-Palmolive Company Low water stannous fluoride plus zinc citrate dentifrice with improved stability, rheology, and efficacy
CN103200994B (en) 2010-01-29 2016-02-10 高露洁-棕榄公司 For the oral care product of sensitive enamel nursing
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
GB201105408D0 (en) 2011-03-30 2011-05-11 Glaxo Group Ltd Composition
CA2858743C (en) 2011-12-20 2019-05-07 Colgate-Palmolive Company Oral care compositions
MX352730B (en) * 2012-12-21 2017-12-06 Gaba Int Holding Ag Oral care composition.
WO2015065968A1 (en) 2013-10-28 2015-05-07 The Procter & Gamble Company Oral care compositions for tooth desensitizing
US9927422B2 (en) 2014-05-13 2018-03-27 The Procter & Gamble Company Method and device for measuring dentin permeability
KR102076268B1 (en) * 2015-04-17 2020-02-11 주식회사 엘지생활건강 Oral composition
WO2016167600A1 (en) * 2015-04-17 2016-10-20 주식회사 엘지생활건강 Oral composition
RU2595875C1 (en) * 2015-09-17 2016-08-27 Игорь Иванович Зоткин Use of zinc or copper (ii) salt as component of oral care composition and oral care composition
MX2018006087A (en) * 2015-11-20 2018-08-24 Colgate Palmolive Co Oral care composition comprising chitosan and silica.
EA037204B1 (en) 2016-04-18 2021-02-19 Юнилевер Н.В. Oral care composition
EA039435B1 (en) 2016-04-18 2022-01-27 ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. Oral care product
GB201607518D0 (en) * 2016-04-29 2016-06-15 Andalay Technologies Ltd Mouthwash composition
WO2021078685A1 (en) 2019-10-23 2021-04-29 Unilever Ip Holdings B.V. Method of reducing dental hypersensitivity
EP3888622A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888623A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888620A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
CN114469989A (en) * 2022-03-15 2022-05-13 北京大学口腔医学院 Cationic hydrogel for tooth desensitization and preparation method and application thereof

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1069832B (en) * 1956-03-01 1959-11-26 Raion-Hamigaki Kabushiki Kaisha (Lion Dentifrice Co., Ltd.) Tokio Transparent toothpaste and method of making it
US3003988A (en) * 1958-10-16 1961-10-10 Clark Cleveland Inc Stabilizer for dentures
US3122483A (en) * 1960-07-21 1964-02-25 Block Drug Co Strontium ion toothpaste
GB1055784A (en) * 1963-06-21 1967-01-18 Unilever Ltd Polishing agent
DE1807299A1 (en) * 1968-11-06 1970-06-04 Bayer Ag Dentifrices containing exchange resins, dental aids, tooth filling compounds, tooth varnishes and other products that come into contact with living teeth
DE2164383A1 (en) * 1971-02-12 1972-08-17 Bartheld, Frits van, Dr., Utrecht (Niederlande) Agents with the demineralization of tooth enamel inhibiting or the mineralization of tooth enamel promoting effect and process for the production of this agent
US3772431A (en) * 1972-09-21 1973-11-13 W Mlkvy Effervescent mouthwash tablet
US3888976A (en) * 1972-09-21 1975-06-10 William P Mlkvy Zinc and strontium ion containing effervescent mouthwash tablet
US3863006A (en) * 1973-01-29 1975-01-28 Milton Hodosh Method for desensitizing teeth
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4296096A (en) * 1979-07-05 1981-10-20 Colgate-Palmolive Company High viscosity dentifrice
US4407675A (en) * 1980-03-03 1983-10-04 Milton Hodosh Composition for preserving dental pulp
US4343608A (en) * 1980-03-03 1982-08-10 Milton Hodosh Compound and method for preserving dental pulp
US4772470A (en) * 1985-04-27 1988-09-20 Nitto Electric Industrial Co., Ltd. Oral bandage and oral preparations
US4906456A (en) * 1986-03-20 1990-03-06 Colgate-Palmolive Company Anticalculus oral composition
US4931273A (en) * 1985-09-13 1990-06-05 Colgate-Palmolive Company Anticalculus oral composition
US4871531A (en) * 1986-02-10 1989-10-03 Hartlaub Gregory R Oral compositions
US4758630A (en) * 1986-10-27 1988-07-19 Richardson-Vicks Inc. Denture stabilizing zinc and strontium salts of ave/ma copolymer
US5032386A (en) * 1988-12-29 1991-07-16 Colgate-Palmolive Company Antiplaque antibacterial oral composition
CA1322960C (en) * 1987-02-12 1993-10-12 Domenico Caserio Dentifrice composition for desensitising sensitive teeth
US4847070A (en) * 1987-10-08 1989-07-11 The Procter & Gamble Company Anticalculus compositions
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
GB8811830D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
US4965067A (en) * 1988-08-10 1990-10-23 The Proctor & Gamble Company Oral compositions
US5139768A (en) * 1989-01-31 1992-08-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental composition for hypersensitive teeth
GB8906914D0 (en) * 1989-03-28 1989-05-10 Beecham Group Plc Novel compositions
US5073604A (en) * 1989-05-04 1991-12-17 Richardson-Vicks, Inc. Denture stabilizing compositions
US5011830A (en) 1989-07-03 1991-04-30 The Proctor & Gamble Company Oral compositions having improved anticalculus properties containing pyrophosphate and an acrylic acid polymer
US4992258A (en) * 1989-10-23 1991-02-12 Colgate-Palmolive Company Dentrifice composition
US4960586A (en) 1989-11-15 1990-10-02 Gillette Canada Inc. Aqueous stannous fluoride non-abrasive home treatment gel compositions
US5017363A (en) * 1989-11-15 1991-05-21 Gillette Canada, Inc. Stabilized stannous fluoride toothpaste
AU644618B2 (en) * 1989-12-28 1993-12-16 G-C Shika Kogyo Kabushiki Kaisha Odontotherapeutical materials
US5234971A (en) * 1989-12-28 1993-08-10 G-C Dental Industrial Corp. Odontotherapeutical materials
GB2240473B (en) * 1990-01-31 1994-06-29 Lion Corp Liquid dentifrice compositions
US5013541A (en) * 1990-04-18 1991-05-07 Conopco, Inc. Poly(alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
US5015467A (en) * 1990-06-26 1991-05-14 The Procter & Gamble Company Combined anticalculus and antiplaque compositions
US5015466A (en) * 1990-06-26 1991-05-14 The Procter & Gamble Company Anticalculus compositions using tartrate-succinates
ES2071336T3 (en) * 1990-10-25 1995-06-16 Boots Co Plc Mouthwash
FR2670383B1 (en) * 1990-12-17 1993-04-09 Scialom Yves INTERMEDIATE PRODUCT FOR FIXING FILLING AMALGAMS IN DENTAL CAVITIES.
US5240509A (en) * 1991-05-28 1993-08-31 Calgon Corporation Method for removing solids from systems containing water-based paints
US5250288A (en) * 1991-09-13 1993-10-05 Gillette Canada, Inc. Method for desensitizing teeth
US5211939A (en) * 1991-09-13 1993-05-18 Gillette Canada Method for desensitizing teeth
US5240569A (en) * 1991-09-30 1993-08-31 Rockwell International Corporation Magnetically enhanced electrolysis cell system
US5240697A (en) * 1991-10-17 1993-08-31 Colgate-Palmolive Company Desensitizing anti-tartar dentifrice
US5270031A (en) * 1991-12-20 1993-12-14 Block Drug Company Inc. Dentinal desensitizing compositions
US5188818A (en) * 1992-03-30 1993-02-23 Isp Investments Inc. Toothpaste composition containing strontium salt of maleic anhydride-methyl vinyl ether copolymer

Also Published As

Publication number Publication date
DK0549281T3 (en) 1999-10-25
AU3014192A (en) 1993-06-24
EP0549281A1 (en) 1993-06-30
CA2085975A1 (en) 1993-06-21
AU655695B2 (en) 1995-01-05
US5653964A (en) 1997-08-05
ES2133309T3 (en) 1999-09-16
KR930012010A (en) 1993-07-20
GR3030422T3 (en) 1999-09-30
PH30209A (en) 1997-02-05
NZ245459A (en) 1997-11-24
EP0549281B1 (en) 1999-04-14
ATE178786T1 (en) 1999-04-15
BR9204695A (en) 1993-06-22
US5270031A (en) 1993-12-14
DE69228922T2 (en) 1999-08-26
DE69228922D1 (en) 1999-05-20
JPH0665083A (en) 1994-03-08
JP2821967B2 (en) 1998-11-05
MX9207317A (en) 1993-06-01
US5597552A (en) 1997-01-28
KR0169140B1 (en) 1999-01-15

Similar Documents

Publication Publication Date Title
CA2085975C (en) Dentinal desensitizing compositions
US20030215401A1 (en) Dental composition for hypersensitve teeth
US6241972B1 (en) Oral care formulation for the treatment of sensitivity teeth
US20070059257A1 (en) Dentinal composition for hypersensitive teeth
JPS61165317A (en) Oral sanitary composition
JPH04334314A (en) Mouthwash composition for preventing tartar
WO2009158564A1 (en) Composition and method for enhancing flouride uptake using bioactive glass
CA2505889A1 (en) Controlled-dissolving polymeric device for the oral cavity
US6096292A (en) Polymeric desensitizing compositions
RU2604667C2 (en) Oral care compositions
US6592853B2 (en) Dentin desensitizer containing stannous fluoride
US20020041852A1 (en) Dental composition for hypersensitive teeth
US9913796B2 (en) Oral care composition containing pumice and calcium carbonate
JPH1017446A (en) Composition for oral cavity
EP3817827A1 (en) Dentifrice comprising a pvm-ma copolymer and a source of free fluoride ions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20101221